↓ Skip to main content

Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity

Overview of attention for article published in Cancer Immunology, Immunotherapy, March 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#5 of 2,959)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
51 news outlets
patent
62 patents

Citations

dimensions_citation
133 Dimensions

Readers on

mendeley
178 Mendeley
Title
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
Published in
Cancer Immunology, Immunotherapy, March 2012
DOI 10.1007/s00262-012-1237-1
Pubmed ID
Authors

Timothy S. Fisher, Cris Kamperschroer, Theodore Oliphant, Victoria A. Love, Paul D. Lira, Regis Doyonnas, Simon Bergqvist, Sangita M. Baxi, Allison Rohner, Amy C. Shen, Chunli Huang, Sharon A. Sokolowski, Leslie L. Sharp

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United Kingdom 1 <1%
United States 1 <1%
Germany 1 <1%
Unknown 174 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 63 35%
Other 22 12%
Student > Ph. D. Student 21 12%
Student > Master 10 6%
Professor 9 5%
Other 23 13%
Unknown 30 17%
Readers by discipline Count As %
Immunology and Microbiology 44 25%
Agricultural and Biological Sciences 35 20%
Biochemistry, Genetics and Molecular Biology 22 12%
Medicine and Dentistry 19 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Other 16 9%
Unknown 32 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 402. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#72,890
of 25,139,853 outputs
Outputs from Cancer Immunology, Immunotherapy
#5
of 2,959 outputs
Outputs of similar age
#252
of 160,897 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 32 outputs
Altmetric has tracked 25,139,853 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,959 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 160,897 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.